Samil PharmaceuticalLtd Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Samil PharmaceuticalLtd.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 34.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
There's Reason For Concern Over Samil Pharmaceutical Co.,Ltd's (KRX:000520) Massive 29% Price Jump
Mar 30
Samil PharmaceuticalLtd's (KRX:000520) Earnings Are Of Questionable Quality
Mar 21Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden
Apr 01Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment
Mar 11Are Dividend Investors Getting More Than They Bargained For With Samil Pharmaceutical Co.,Ltd's (KRX:000520) Dividend?
Feb 15
Should You Be Concerned About Samil Pharmaceutical Co.,Ltd's (KRX:000520) ROE?
Jan 20Why It Might Not Make Sense To Buy Samil Pharmaceutical Co.,Ltd (KRX:000520) For Its Upcoming Dividend
Dec 24Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 221% Total Return On Their Investment
Dec 09What Is The Ownership Structure Like For Samil Pharmaceutical Co.,Ltd (KRX:000520)?
Nov 18In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Samil PharmaceuticalLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 196,346 | 1,664 | -12,590 | 11,746 | N/A |
| 9/30/2023 | 189,293 | 2,600 | -18,707 | -43,369 | N/A |
| 6/30/2023 | 183,060 | 1,336 | -28,155 | -12,562 | N/A |
| 3/31/2023 | 179,566 | 343 | -33,560 | 3,887 | N/A |
| 12/31/2022 | 179,676 | -28 | -44,502 | 4,154 | N/A |
| 9/30/2022 | 170,510 | -4,989 | -53,802 | 41,099 | N/A |
| 6/30/2022 | 158,910 | -4,740 | -40,593 | 15,161 | N/A |
| 3/31/2022 | 147,877 | -5,619 | -34,933 | 1,437 | N/A |
| 12/31/2021 | 134,247 | -5,347 | -31,194 | 1,417 | N/A |
| 9/30/2021 | 129,974 | -2,761 | -24,913 | -1,229 | N/A |
| 6/30/2021 | 127,287 | -1,327 | -20,164 | 119 | N/A |
| 3/31/2021 | 122,793 | 132 | -20,038 | 4,736 | N/A |
| 12/31/2020 | 122,999 | 1,341 | -9,436 | 7,775 | N/A |
| 9/30/2020 | 123,114 | 940 | 2,747 | 15,430 | N/A |
| 6/30/2020 | 122,308 | 729 | -9,557 | 11,450 | N/A |
| 3/31/2020 | 123,102 | 1,429 | 2,486 | 16,455 | N/A |
| 12/31/2019 | 121,107 | 786 | -3,729 | 10,590 | N/A |
| 9/30/2019 | 114,364 | -1,251 | -13,267 | 40 | N/A |
| 6/30/2019 | 107,856 | -3,368 | -5 | 4,677 | N/A |
| 3/31/2019 | 102,805 | -6,461 | -7,234 | -2,305 | N/A |
| 12/31/2018 | 94,600 | -8,563 | -6,538 | -2,622 | N/A |
| 9/30/2018 | 96,882 | -5,165 | -2,899 | 1,319 | N/A |
| 6/30/2018 | 94,916 | -4,605 | -3,035 | 2,217 | N/A |
| 3/31/2018 | 92,286 | -2,797 | -40,013 | 3,258 | N/A |
| 12/31/2017 | 92,038 | -1,267 | -39,393 | 3,791 | N/A |
| 9/30/2017 | 90,658 | -1,434 | N/A | -680 | N/A |
| 6/30/2017 | 92,118 | 898 | N/A | 1,539 | N/A |
| 3/31/2017 | 94,685 | 948 | N/A | 5,206 | N/A |
| 12/31/2016 | 96,758 | 887 | N/A | 5,634 | N/A |
| 9/30/2016 | 94,010 | 306 | N/A | 9,953 | N/A |
| 6/30/2016 | 92,625 | 140 | N/A | 5,840 | N/A |
| 3/31/2016 | 88,656 | 553 | N/A | 1,357 | N/A |
| 12/31/2015 | 88,136 | 588 | N/A | 2,920 | N/A |
| 9/30/2015 | 85,795 | -2,986 | N/A | -1,492 | N/A |
| 6/30/2015 | 85,439 | -6,170 | N/A | -4,921 | N/A |
| 3/31/2015 | 85,849 | -10,179 | N/A | -11,314 | N/A |
| 12/31/2014 | 85,461 | -11,190 | N/A | -11,923 | N/A |
| 9/30/2014 | 87,683 | 1,148 | N/A | -12,731 | N/A |
| 6/30/2014 | 87,545 | 3,601 | N/A | -6,621 | N/A |
| 3/31/2014 | 89,207 | 7,191 | N/A | -586 | N/A |
| 12/31/2013 | 89,229 | 7,930 | N/A | -3,990 | N/A |
| 9/30/2013 | 89,993 | -2,029 | N/A | -6,076 | N/A |
| 6/30/2013 | 91,235 | -1,321 | N/A | -6,909 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A000520's forecast earnings growth is above the savings rate (2.5%).
Earnings vs Market: Insufficient data to determine if A000520's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A000520's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A000520's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A000520's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A000520's Return on Equity is forecast to be high in 3 years time